Advisor

Cecilia Hahn, J.D. - Regulatory Affairs

Ms. Hahn serves as the Chief Regulatory Officer responsible for overseeing IP development and bringing these products to market. She encompasses an Executive Juris Doctorate with concentrated studies in Health and Business Law, and 15 years of health industry experience. Ms. Hahn has liaised with the top pharmaceutical, biotech, and medical device companies in the world while implementing her knowledge and thorough understanding of international business laws, health laws, and international regulations involved in clinical research studies and drug/device approval. As the Director of Legal & Regulatory Affairs of Clinical Research Networks, Inc. Ms. Hahn supervised 150+ clinical trials globally through the stages of pre-clinical research, clinical trial(s), and market approval. Ms. Hahn is a member of the Regulatory Affairs Professional Society.